This is a table of type noun and their frequencies. Use it to search & browse the list to learn more about your study carrel.
noun | frequency |
---|---|
patients | 22257 |
cells | 14821 |
blood | 13531 |
cell | 13486 |
results | 6283 |
donors | 5437 |
donor | 5418 |
disease | 5298 |
study | 5048 |
group | 4653 |
transfusion | 4639 |
treatment | 4383 |
transplantation | 4336 |
days | 3950 |
time | 3861 |
risk | 3765 |
years | 3745 |
data | 3684 |
patient | 3661 |
response | 3635 |
analysis | 3624 |
methods | 3491 |
day | 3310 |
expression | 3146 |
transplant | 3141 |
infection | 3050 |
months | 3048 |
stem | 2970 |
age | 2797 |
platelet | 2693 |
cases | 2686 |
number | 2669 |
antigen | 2608 |
survival | 2607 |
protein | 2596 |
system | 2543 |
antibodies | 2540 |
mice | 2534 |
samples | 2531 |
therapy | 2520 |
levels | 2478 |
virus | 2427 |
epitopes | 2364 |
graft | 2355 |
plasma | 2278 |
pts | 2247 |
antibody | 2239 |
peptides | 2230 |
use | 2228 |
peptide | 2135 |
studies | 2124 |
class | 2036 |
type | 2001 |
responses | 1979 |
groups | 1933 |
conditioning | 1900 |
units | 1883 |
control | 1864 |
vaccine | 1861 |
dose | 1823 |
incidence | 1790 |
relapse | 1753 |
method | 1729 |
population | 1722 |
range | 1681 |
ml | 1661 |
recipients | 1655 |
antigens | 1641 |
role | 1637 |
factors | 1609 |
development | 1588 |
gene | 1581 |
conclusion | 1581 |
level | 1570 |
rate | 1561 |
test | 1555 |
effect | 1544 |
infections | 1533 |
epitope | 1485 |
donation | 1466 |
mortality | 1459 |
proteins | 1456 |
marrow | 1447 |
activation | 1445 |
host | 1436 |
background | 1431 |
bone | 1421 |
products | 1407 |
children | 1402 |
period | 1396 |
diagnosis | 1394 |
year | 1382 |
activity | 1359 |
platelets | 1356 |
molecules | 1335 |
presence | 1328 |
function | 1321 |
production | 1316 |
testing | 1315 |
case | 1267 |
regimen | 1262 |
quality | 1262 |
factor | 1244 |
grade | 1240 |
outcome | 1217 |
effects | 1216 |
serum | 1211 |
conclusions | 1188 |
follow | 1185 |
model | 1182 |
receptor | 1181 |
syndrome | 1170 |
reactions | 1152 |
diseases | 1144 |
addition | 1129 |
rejection | 1127 |
failure | 1127 |
collection | 1123 |
process | 1109 |
safety | 1105 |
allogeneic | 1096 |
lymphocytes | 1083 |
drug | 1070 |
allo | 1066 |
components | 1054 |
genes | 1049 |
term | 1029 |
prophylaxis | 1026 |
approach | 1022 |
differences | 1019 |
disclosure | 1013 |
post | 1009 |
assay | 1006 |
leukemia | 1005 |
complications | 990 |
frequency | 984 |
alleles | 981 |
increase | 981 |
surface | 960 |
storage | 960 |
outcomes | 960 |
screening | 956 |
order | 952 |
lung | 949 |
procedure | 944 |
liver | 942 |
median | 940 |
dna | 938 |
none | 914 |
impact | 907 |
status | 906 |
engraftment | 899 |
rbcs | 889 |
rates | 886 |
reduction | 884 |
difference | 881 |
sample | 879 |
transfusions | 870 |
induction | 869 |
flow | 867 |
sequence | 858 |
phenotype | 856 |
recipient | 856 |
detection | 853 |
information | 841 |
evidence | 837 |
count | 836 |
recovery | 835 |
cohort | 833 |
chemotherapy | 831 |
center | 830 |
influenza | 830 |
events | 830 |
phase | 827 |
immunity | 821 |
target | 810 |
acid | 805 |
findings | 800 |
volume | 799 |
weeks | 794 |
interest | 793 |
product | 792 |
identification | 791 |
hospital | 791 |
table | 791 |
skin | 791 |
total | 789 |
tests | 786 |
changes | 783 |
criteria | 779 |
reaction | 776 |
kg | 769 |
vaccines | 756 |
management | 756 |
donations | 754 |
tissue | 754 |
unit | 753 |
individuals | 751 |
allele | 750 |
loss | 749 |
value | 748 |
remission | 748 |
controls | 745 |
assays | 741 |
efficacy | 739 |
selection | 739 |
life | 736 |
tumor | 735 |
laboratory | 733 |
procedures | 730 |
lymphoma | 730 |
apheresis | 727 |
memory | 725 |
symptoms | 720 |
score | 717 |
iron | 716 |
vivo | 706 |
line | 705 |
specificity | 704 |
values | 690 |
lymphocyte | 686 |
toxicity | 683 |
aim | 677 |
cytokine | 674 |
culture | 674 |
cord | 674 |
death | 672 |
deficiency | 668 |
source | 657 |
region | 654 |
proliferation | 649 |
presentation | 646 |
health | 644 |
concentration | 640 |
i | 639 |
adult | 627 |
cancer | 626 |
care | 625 |
prevalence | 625 |
models | 624 |
combination | 623 |
protocol | 622 |
centers | 616 |
populations | 609 |
binding | 609 |
stimulation | 608 |
viruses | 606 |
processing | 605 |
absence | 604 |
progression | 604 |
chimerism | 603 |
family | 602 |
anemia | 601 |
types | 600 |
cytokines | 600 |
introduction | 599 |
women | 597 |
parameters | 596 |
association | 596 |
° | 595 |
prediction | 591 |
cytometry | 588 |
transplants | 587 |
reactivation | 587 |
interaction | 587 |
mutations | 586 |
mechanisms | 585 |
result | 584 |
weight | 582 |
kidney | 581 |
ability | 578 |
characteristics | 575 |
doses | 575 |
hours | 574 |
residues | 573 |
conditions | 572 |
mouse | 569 |
amino | 567 |
administration | 567 |
sequences | 566 |
intensity | 565 |
infusion | 565 |
neutrophil | 564 |
evaluation | 557 |
systems | 557 |
countries | 556 |
experience | 555 |
majority | 552 |
contrast | 552 |
comparison | 552 |
ratio | 551 |
chain | 547 |
receptors | 544 |
drugs | 544 |
strategy | 541 |
work | 540 |
subjects | 540 |
conflict | 540 |
strategies | 538 |
reactivity | 537 |
need | 529 |
improvement | 529 |
recognition | 528 |
cause | 527 |
regimens | 523 |
cost | 520 |
correlation | 517 |
sensitivity | 516 |
lines | 515 |
part | 513 |
affinity | 508 |
analyses | 507 |
trial | 505 |
grafts | 505 |
practice | 504 |
pathway | 502 |
growth | 502 |
research | 502 |
numbers | 499 |
vaccination | 498 |
surgery | 498 |
times | 495 |
structure | 493 |
protection | 493 |
pathogen | 491 |
mutation | 491 |
mechanism | 491 |
site | 490 |
history | 489 |
potential | 487 |
distribution | 483 |
course | 483 |
mobilization | 482 |
clones | 481 |
percentage | 480 |
sibling | 479 |
regions | 476 |
interactions | 476 |
release | 475 |
membrane | 474 |
organ | 473 |
depletion | 473 |
markers | 471 |
inflammation | 470 |
generation | 466 |
malignancies | 464 |
finding | 460 |
body | 460 |
onset | 455 |
capacity | 454 |
duration | 454 |
performance | 452 |
allograft | 450 |
molecule | 449 |
macrophages | 449 |
lack | 447 |
complex | 447 |
review | 445 |
program | 445 |
agents | 444 |
monocytes | 439 |
end | 439 |
× | 439 |
hospitals | 436 |
min | 435 |
variants | 434 |
disorders | 432 |
cross | 432 |
auto | 429 |
implementation | 428 |
hct | 426 |
co | 426 |
injury | 425 |
stage | 423 |
month | 420 |
regulation | 418 |
design | 418 |
basis | 418 |
gvhd | 416 |
assessment | 416 |
exposure | 414 |
hemoglobin | 412 |
reconstitution | 411 |
typing | 409 |
arthritis | 408 |
immunosuppression | 407 |
bacteria | 406 |
tolerance | 406 |
component | 405 |
trials | 404 |
report | 404 |
staff | 403 |
neutrophils | 403 |
change | 402 |
application | 398 |
setting | 398 |
decrease | 398 |
severity | 397 |
immunization | 396 |
features | 396 |
self | 395 |
igg | 395 |
dl | 395 |
complication | 395 |
coronavirus | 393 |
date | 393 |
knowledge | 392 |
sites | 390 |
event | 389 |
step | 385 |
pathogens | 385 |
myeloma | 384 |
week | 383 |
expansion | 383 |
involvement | 382 |
side | 381 |
panel | 379 |
agvhd | 376 |
size | 375 |
strains | 374 |
bank | 373 |
leukocyte | 372 |
guidelines | 372 |
tool | 369 |
technique | 369 |
fever | 368 |
genotype | 366 |
ferritin | 365 |
proportion | 365 |
solution | 363 |
medicine | 363 |
sequencing | 363 |
point | 362 |
cultures | 360 |
adults | 360 |
transmission | 356 |
spleen | 356 |
differentiation | 355 |
pattern | 352 |
form | 349 |
database | 349 |
option | 349 |
nothing | 349 |
reports | 348 |
marker | 348 |
complexes | 348 |
susceptibility | 347 |
sepsis | 343 |
monitoring | 342 |
formation | 342 |
morbidity | 342 |
sex | 342 |
ligand | 341 |
subsets | 339 |
authors | 339 |
others | 338 |
males | 338 |
genome | 338 |
length | 337 |
hepatitis | 337 |
apoptosis | 336 |
service | 336 |
gamma | 334 |
effector | 334 |
challenge | 334 |
experiments | 333 |
lesions | 332 |
importance | 332 |
humans | 332 |
enzyme | 332 |
concentrations | 332 |
animals | 328 |
support | 328 |
females | 327 |
inhibition | 327 |
terms | 325 |
state | 325 |
spike | 325 |
inhibitor | 325 |
domain | 325 |
variation | 323 |
tissues | 323 |
series | 323 |
processes | 322 |
targets | 322 |
resistance | 322 |
pc | 320 |
acids | 319 |
validation | 317 |
profile | 316 |
delivery | 316 |
training | 314 |
services | 312 |
resolution | 312 |
gel | 311 |
myeloid | 311 |
glycoprotein | 310 |
technology | 309 |
techniques | 309 |
set | 309 |
counts | 309 |
regression | 308 |
maintenance | 308 |
content | 308 |
pcs | 307 |
pathogenesis | 306 |
mg | 306 |
immunogenicity | 303 |
biopsies | 302 |
scores | 302 |
supply | 301 |
preparation | 301 |
investigation | 301 |
repertoire | 300 |
prevention | 300 |
immunodeficiency | 300 |
index | 299 |
causes | 299 |
functions | 298 |
signs | 298 |
thrombocytopenia | 297 |
pregnancy | 297 |
approaches | 297 |
way | 296 |
prognosis | 296 |
interferon | 294 |
pool | 293 |
agent | 293 |
inhibitors | 292 |
irradiation | 292 |
pools | 292 |
reference | 292 |
properties | 291 |
os | 291 |
contamination | 290 |
amount | 290 |
biopsy | 288 |
significance | 287 |
genotyping | 287 |
damage | 287 |
risks | 285 |
context | 284 |
temperature | 284 |
areas | 283 |
immunoglobulin | 283 |
frequencies | 283 |
fact | 282 |
requirements | 281 |
replication | 281 |
load | 281 |
literature | 281 |
survey | 280 |
occurrence | 280 |
cgvhd | 280 |
cr | 279 |
phenotypes | 278 |
cyclophosphamide | 277 |
diversity | 277 |
rhd | 276 |
software | 275 |
objective | 275 |
filtration | 275 |
problem | 271 |
area | 271 |
clearance | 270 |
ci | 270 |
polymorphisms | 270 |
relationship | 269 |
transfer | 268 |
availability | 268 |
degree | 267 |
structures | 266 |
variant | 265 |
transcription | 265 |
materials | 265 |
interval | 265 |
efficiency | 264 |
titer | 263 |
purpose | 263 |
candidate | 262 |
tools | 261 |
institution | 261 |
heart | 260 |
gender | 259 |
neutropenia | 257 |
activities | 256 |
deferral | 256 |
origin | 256 |
species | 256 |
yield | 256 |
trend | 255 |
secretion | 255 |
kit | 255 |
world | 254 |
effectiveness | 254 |
alloantibodies | 254 |
busulfan | 253 |
cluster | 251 |
organs | 251 |
reasons | 250 |
probability | 250 |
patterns | 250 |
episodes | 250 |
signal | 249 |
points | 249 |
hemolysis | 249 |
tumors | 248 |
scale | 248 |
example | 247 |
predictions | 247 |
titers | 245 |
steroid | 244 |
alloimmunization | 244 |
material | 243 |
determination | 243 |
server | 242 |
percent | 242 |
histocompatibility | 242 |
pathways | 240 |
polymorphism | 240 |
viability | 240 |
therapies | 239 |
condition | 238 |
minutes | 237 |
ng | 236 |
collections | 236 |
strain | 235 |
inactivation | 235 |
device | 235 |
pneumonia | 234 |
influence | 234 |
tuberculosis | 234 |
vector | 234 |
variables | 232 |
lymph | 232 |
cycle | 232 |
mscs | 231 |
country | 231 |
tube | 230 |
steps | 230 |
observation | 230 |
helper | 230 |
education | 229 |
measures | 229 |
reagents | 229 |
policy | 228 |
ligands | 228 |
alpha | 228 |
pain | 227 |
usage | 226 |
indications | 226 |
centre | 226 |
male | 225 |
candidates | 225 |
medium | 224 |
protocols | 224 |
treatments | 223 |
suppression | 223 |
density | 221 |
thalassemia | 220 |
forms | 220 |
dysfunction | 220 |
animal | 220 |
genotypes | 219 |
banks | 219 |
mud | 218 |
problems | 218 |
salvage | 218 |
consensus | 217 |
benefit | 217 |
replacement | 216 |
inventory | 216 |
incubation | 216 |
contact | 216 |
clusters | 216 |
algorithm | 215 |
beta | 215 |
brain | 215 |
exon | 215 |
oxygen | 215 |
understanding | 215 |
deletion | 214 |
coagulation | 214 |
¥ | 213 |
synthesis | 213 |
staining | 213 |
pressure | 213 |
fraction | 212 |
escape | 212 |
immunotherapy | 211 |
specimens | 211 |
errors | 210 |
screen | 210 |
recruitment | 209 |
hypothesis | 209 |
hr | 209 |
arm | 209 |
albumin | 209 |
goal | 208 |
abnormalities | 208 |
people | 206 |
malignancy | 206 |
possibility | 206 |
version | 206 |
place | 205 |
search | 205 |
mother | 204 |
glucose | 204 |
cytotoxicity | 203 |
costs | 202 |
pbmcs | 201 |
leukocytes | 201 |
field | 201 |
men | 200 |
complement | 200 |
granulocyte | 200 |
steroids | 200 |
objectives | 200 |
participants | 200 |
summary | 199 |
respect | 199 |
macrophage | 199 |
cycles | 198 |
migration | 198 |
disorder | 198 |
manner | 198 |
threshold | 198 |
standard | 198 |
records | 198 |
survivors | 197 |
maturation | 197 |
initiation | 197 |
coverage | 197 |
energy | 196 |
anaemia | 196 |
access | 196 |
injection | 196 |
members | 196 |
variability | 195 |
position | 195 |
pairs | 195 |
gut | 195 |
promoter | 194 |
room | 193 |
mass | 193 |
fludarabine | 193 |
cyclosporine | 193 |
discovery | 192 |
bag | 192 |
questions | 192 |
necrosis | 192 |
haplo | 191 |
stability | 190 |
mismatch | 190 |
indication | 189 |
hand | 189 |
environment | 189 |
intervention | 188 |
ii | 188 |
core | 187 |
admission | 187 |
agglutination | 187 |
trauma | 187 |
cryopreservation | 187 |
docking | 187 |
incompatibility | 187 |
questionnaire | 186 |
elements | 186 |
means | 185 |
deaths | 184 |
globulin | 184 |
nature | 183 |
bags | 183 |
consent | 183 |
tract | 183 |
reason | 183 |
surveillance | 183 |
exchange | 182 |
domains | 182 |
car | 181 |
standards | 180 |
subset | 180 |
team | 179 |
residue | 179 |
mean | 179 |
lysis | 179 |
human | 179 |
calcium | 179 |
stages | 178 |
classification | 178 |
thymus | 177 |
infants | 177 |
yrs | 177 |
issue | 176 |
female | 176 |
anti | 176 |
platform | 176 |
evolution | 175 |
practices | 174 |
network | 174 |
examination | 174 |
clone | 174 |
infiltration | 173 |
autoantibodies | 173 |
characterization | 173 |
panels | 173 |
islet | 173 |
killer | 173 |
silico | 173 |
signals | 172 |
project | 172 |
physicians | 172 |
measurement | 172 |
manifestations | 172 |
child | 171 |
† | 171 |
birth | 171 |
copies | 170 |
repeat | 169 |
column | 169 |
progenitor | 169 |
fluorescence | 169 |
consumption | 168 |
pt | 168 |
success | 167 |
chains | 167 |
blasts | 167 |
spectrum | 166 |
entry | 166 |
ad | 166 |
cohorts | 165 |
average | 165 |
sd | 165 |
creatinine | 165 |
implications | 165 |
pandemic | 164 |
erythrocytes | 164 |
allografts | 164 |
advantage | 164 |
diabetes | 163 |
half | 163 |
media | 163 |
organization | 163 |
variety | 162 |
filter | 162 |
corticosteroids | 162 |
serology | 161 |
predictors | 161 |
leukaemia | 161 |
issues | 161 |
baseline | 161 |
bleeding | 160 |
shock | 160 |
volunteers | 159 |
reagent | 159 |
progress | 159 |
infusions | 159 |
inclusion | 159 |
immune | 159 |
centres | 159 |
a. | 158 |
hospitalization | 158 |
extent | 158 |
chromosome | 157 |
fusion | 157 |
restriction | 156 |
hypertension | 156 |
accumulation | 156 |
measurements | 156 |
dynamics | 155 |
action | 155 |
concern | 155 |
intervals | 155 |
kinase | 155 |
mrna | 154 |
fibrosis | 154 |
efforts | 154 |
challenges | 154 |
adhesion | 154 |
accuracy | 154 |
subunit | 154 |
programs | 153 |
centrifugation | 153 |
specificities | 153 |
water | 153 |
resources | 151 |
mononuclear | 151 |
locus | 151 |
laboratories | 151 |
erythrocyte | 151 |
amounts | 151 |
decision | 150 |
haplotype | 150 |
predictor | 150 |
recommendations | 150 |
sickle | 150 |
registry | 149 |
matrix | 149 |
lupus | 149 |
equipment | 149 |
malaria | 148 |
hemorrhage | 148 |
alterations | 148 |
peak | 147 |
profiles | 147 |
throughput | 146 |
novel | 146 |
subtypes | 145 |
banking | 145 |
transport | 144 |
terminal | 143 |
dcs | 143 |
base | 143 |
choice | 143 |
simulation | 143 |
emergency | 143 |
responders | 143 |
sources | 142 |
recurrence | 142 |
nodes | 142 |
match | 142 |
log | 142 |
loci | 142 |
aspects | 141 |
interventions | 140 |
burden | 140 |
error | 140 |
exons | 140 |
requirement | 140 |
medication | 140 |
microscopy | 140 |
stress | 140 |
β | 140 |
colony | 139 |
categories | 139 |
concept | 138 |
autoimmunity | 138 |
compliance | 138 |
utilization | 138 |
crossmatch | 138 |
settings | 138 |
nm | 138 |
positivity | 137 |
alternative | 137 |
ctls | 137 |
colitis | 137 |
question | 137 |
technologies | 137 |
tumour | 137 |
preprint | 136 |
plerixafor | 136 |
particles | 136 |
matching | 136 |
category | 135 |
elimination | 135 |
periods | 135 |
relation | 135 |
retention | 135 |
saline | 135 |
separation | 135 |
tacrolimus | 134 |
preparations | 134 |
kinetics | 134 |
isolation | 134 |
fibrinogen | 134 |
consolidation | 134 |
alloantibody | 134 |
physician | 133 |
one | 133 |
needs | 133 |
composition | 133 |
collagen | 133 |
siblings | 132 |
cleavage | 132 |
antibiotics | 132 |
ab | 131 |
amplification | 131 |
future | 131 |
transduction | 131 |
ifnγ | 131 |
placebo | 130 |
options | 130 |
ones | 130 |
metabolism | 130 |
measure | 130 |
antiglobulin | 130 |
diarrhea | 129 |
associations | 129 |
consequence | 129 |
limit | 129 |
enzymes | 129 |
rat | 129 |
limitations | 128 |
hypersensitivity | 128 |
fluid | 128 |
concentrates | 127 |
feasibility | 127 |
n=2 | 127 |
hour | 127 |
subgroups | 127 |
vs. | 126 |
ph | 126 |
journal | 126 |
investigations | 126 |
institutions | 126 |
fetus | 126 |
defects | 126 |
newborns | 125 |
salt | 125 |
start | 125 |
woman | 124 |
title | 124 |
situation | 124 |
observations | 124 |
mutants | 124 |
lungs | 124 |
consideration | 124 |
defect | 123 |
csf | 123 |
hydrogen | 123 |
demand | 123 |
rise | 122 |
regard | 122 |
list | 122 |
degradation | 122 |
adjuvant | 122 |
rabbit | 121 |
n=3 | 121 |
member | 121 |
resource | 120 |
personnel | 120 |
fragments | 120 |
consequences | 120 |
hematocrit | 119 |
confidence | 119 |
emergence | 119 |
clinicians | 119 |
pathology | 119 |
situations | 119 |
phenomenon | 119 |
rccs | 119 |
sampling | 118 |
web | 118 |
lactate | 118 |
removal | 118 |
attention | 118 |
tetramer | 118 |
thymocytes | 118 |
tyrosine | 118 |
relevance | 117 |
edema | 117 |
dilution | 117 |
compartment | 117 |
communication | 117 |
biology | 117 |
benefits | 117 |
supernatants | 117 |
phosphorylation | 116 |
community | 116 |
ifitm1 | 116 |
sclerosis | 116 |
vectors | 116 |
insulin | 115 |
combinations | 115 |
determinants | 115 |
extraction | 115 |
appearance | 115 |
lab | 115 |
lineage | 115 |
medications | 115 |
strength | 115 |
toxicities | 115 |
transplantations | 114 |
states | 114 |
positions | 114 |
manufacturing | 114 |
help | 114 |
account | 114 |
endpoint | 113 |
establishment | 113 |
mab | 113 |
kidneys | 113 |
lipid | 113 |
individual | 113 |
persistence | 113 |
rank | 113 |
rheumatoid | 113 |
sets | 113 |
variations | 113 |
i1 | 112 |
courses | 112 |
discussion | 112 |
viremia | 112 |
light | 112 |
substitution | 112 |
urine | 111 |
manufacturer | 111 |
cord_uid | 111 |
apcs | 111 |
antigenicity | 111 |
focus | 110 |
buffer | 110 |
csa | 110 |
imaging | 110 |
plts | 110 |
polymerase | 110 |
roles | 110 |
subgroup | 110 |
rats | 109 |
iels | 109 |
deferrals | 109 |
compatibility | 109 |
circulation | 109 |
lymphomas | 108 |
contribution | 108 |
fi | 108 |
precursor | 108 |
overload | 108 |
rest | 108 |
pilot | 108 |
exclusion | 107 |
adherence | 107 |
bonds | 107 |
agreement | 107 |
haemoglobin | 107 |
non | 107 |
posttransplant | 107 |
students | 107 |
promiscuity | 106 |
parasite | 106 |
paper | 106 |
discontinuation | 106 |
cm | 106 |
phagocytosis | 105 |
immunology | 105 |
license | 105 |
tcrs | 105 |
progenitors | 105 |
rabbits | 105 |
window | 104 |
era | 104 |
enrichment | 104 |
concentrate | 104 |
coli | 104 |
biomarkers | 104 |
view | 103 |
ptcy | 103 |
interface | 103 |
department | 103 |
concerns | 103 |
effort | 102 |
advantages | 102 |
breast | 102 |
confirmation | 102 |
ifng | 102 |
modification | 102 |
protease | 102 |
man | 102 |
computer | 101 |
algorithms | 101 |
binders | 101 |
carcinoma | 101 |
chemokine | 101 |
collaboration | 101 |
fractionation | 101 |
image | 101 |
increases | 101 |
quantification | 101 |
syndromes | 101 |
plan | 100 |
homology | 100 |
improvements | 100 |
label | 100 |
pas | 100 |
alloreactivity | 100 |
precursors | 100 |
volumes | 100 |
wt | 100 |
⩾ | 100 |
stay | 100 |
deviation | 99 |
chemokines | 99 |
deficiencies | 99 |
decline | 99 |
granulocytes | 99 |
impairment | 99 |
isolates | 99 |
wastage | 99 |
pg | 98 |
mediators | 98 |
additive | 98 |
actions | 97 |
author | 97 |
comparisons | 97 |
dosage | 97 |
haplotypes | 97 |
lesion | 97 |
location | 97 |
microbiota | 97 |
mismatches | 97 |
mmf | 97 |
mode | 97 |
modulation | 97 |
reporting | 97 |
cytogenetics | 96 |
dress | 96 |
fragment | 96 |
mapping | 96 |
plasmapheresis | 96 |
radiation | 96 |
syngeneic | 96 |
withdrawal | 96 |
supertypes | 95 |
grouping | 95 |
feature | 95 |
episode | 95 |
definition | 95 |
blast | 94 |
identity | 94 |
lfs | 94 |
methodology | 94 |
uv | 94 |
suppressor | 94 |
programme | 93 |
balance | 93 |
comorbidities | 93 |
kits | 93 |
pregnancies | 93 |
segment | 93 |
timing | 93 |
vaccinia | 93 |
washing | 93 |
mothers | 92 |
applications | 92 |
conversion | 92 |
incidences | 92 |
instrument | 92 |
α | 92 |
nurses | 92 |
pcr | 92 |
return | 92 |
signaling | 92 |
node | 91 |
analyzer | 91 |
schedule | 91 |
phenotyping | 91 |
cystitis | 90 |
accordance | 90 |
adenovirus | 90 |
upregulation | 90 |
cancers | 90 |
coronaviruses | 90 |
blot | 90 |
doctors | 90 |
fractions | 90 |
heterogeneity | 90 |
loop | 90 |
organisms | 90 |
arms | 89 |
awareness | 89 |
bilirubin | 89 |
bridge | 89 |
families | 89 |
enhancement | 89 |
erythematosus | 89 |
childhood | 89 |
hematology | 89 |
parents | 89 |
vaccinology | 89 |
uptake | 89 |
islets | 89 |
mm | 89 |
layer | 89 |
magnitude | 89 |
subpopulations | 88 |
priming | 88 |
hazard | 88 |
correction | 88 |
conservation | 88 |
approval | 88 |
solutions | 88 |
multiepitope | 87 |
constructs | 87 |
cp | 87 |
curve | 87 |
eruption | 87 |
infant | 87 |
insight | 87 |
decades | 87 |
muscle | 87 |
ratios | 87 |
nanoparticles | 87 |
symptom | 87 |
supernatant | 87 |
destruction | 87 |
precision | 87 |
outbreak | 87 |
ischemia | 86 |
beginning | 86 |
details | 86 |
fibroblasts | 86 |
grades | 86 |
instructions | 86 |
primers | 86 |
relapses | 86 |
request | 86 |
rituximab | 86 |
tetramers | 86 |
purification | 86 |
gram | 85 |
anchor | 85 |
carriers | 85 |
examples | 85 |
insights | 85 |
groove | 85 |
turn | 85 |
key | 85 |
subtype | 85 |
tap | 84 |
melanoma | 84 |
mb | 84 |
interpretation | 84 |
illness | 84 |
il-2 | 84 |
hscs | 84 |
heparin | 84 |
chromatography | 84 |
chest | 84 |
attempt | 84 |
specimen | 84 |
mixture | 83 |
decade | 83 |
discrepancies | 83 |
modifications | 83 |
persons | 83 |
th1 | 83 |
motif | 82 |
advances | 82 |
cards | 82 |
vitamin | 82 |
proteasome | 82 |
proteome | 82 |
ventilation | 81 |
segments | 81 |
interference | 81 |
devices | 81 |
delta | 81 |
thrombosis | 81 |
defense | 80 |
8) | 80 |
aggregation | 80 |
bioinformatics | 80 |
cdna | 80 |
conformation | 80 |
dataset | 80 |
distance | 80 |
feedback | 80 |
home | 80 |
pneumoniae | 80 |
space | 80 |
substitutions | 80 |
etiology | 80 |
construct | 79 |
barrier | 79 |
basal | 79 |
blockade | 79 |
bowel | 79 |
engagement | 79 |
curves | 79 |
infectivity | 79 |
measles | 79 |
mg/ | 79 |
suspension | 79 |
operations | 78 |
discharge | 78 |
failures | 78 |
healthcare | 78 |
joints | 78 |
membranes | 78 |
purity | 78 |
sheep | 78 |
shift | 78 |
spots | 78 |
transcripts | 78 |
transmembrane | 78 |
isoniazid | 77 |
endpoints | 77 |
erythema | 77 |
establishments | 77 |
framework | 77 |
gag | 77 |
gradient | 77 |
leukapheresis | 77 |
microorganisms | 77 |
motifs | 77 |
power | 77 |
separator | 77 |
transformation | 77 |
opportunity | 76 |
asthma | 76 |
cd8 | 76 |
chance | 76 |
documentation | 76 |
fold | 76 |
moment | 76 |
sensitization | 76 |
orders | 76 |
supplementation | 76 |
utility | 76 |
parts | 76 |
scan | 76 |
rr | 76 |
similarity | 75 |
seroconversion | 75 |
scoring | 75 |
genetics | 75 |
envelope | 75 |
automation | 75 |
array | 75 |
adolescents | 75 |
present | 75 |
papillomavirus | 74 |
clinic | 74 |
lectin | 74 |
mast | 74 |
newborn | 74 |
positives | 74 |
pr | 74 |
responsiveness | 74 |
γ | 74 |
catheter | 73 |
efs | 73 |
element | 73 |
epidemiology | 73 |
glycoproteins | 73 |
grading | 73 |
haec | 73 |
increment | 73 |
machine | 73 |
quantity | 73 |
sodium | 73 |
vein | 73 |
direction | 72 |
estimates | 72 |
eruptions | 72 |
discrepancy | 72 |
gestation | 72 |
cure | 72 |
corticosteroid | 72 |
beads | 72 |
b6 | 72 |
ex | 72 |
complexity | 72 |
harvest | 72 |
p. | 72 |
indicators | 72 |
plasmid | 72 |
preservation | 72 |
percentages | 72 |
phases | 72 |
n=8 | 72 |
manifestation | 72 |
karyotype | 72 |
input | 72 |
likelihood | 71 |
1a | 71 |
airway | 71 |
diagnoses | 71 |
epithelium | 71 |
haemovigilance | 71 |
interleukin | 71 |
killing | 71 |
necrolysis | 71 |
person | 71 |
probes | 71 |
route | 71 |
subject | 71 |
syphilis | 71 |
terminus | 71 |
Å | 71 |
note | 71 |
library | 70 |
exception | 70 |
house | 70 |
histology | 70 |
filters | 70 |
+ | 70 |
deposition | 70 |
colon | 70 |
coat | 70 |
labeling | 70 |
chart | 70 |
optimization | 70 |
stimuli | 70 |
parasites | 70 |
volunteer | 70 |
sub | 70 |
transfection | 70 |
record | 70 |
radiotherapy | 70 |
race | 70 |
proportions | 70 |
networks | 69 |
adsorption | 69 |
affinities | 69 |
cxcr4 | 69 |
fibrin | 69 |
guidance | 69 |
immunofluorescence | 69 |
incorporation | 69 |
localization | 69 |
correlations | 69 |
neutralization | 69 |
section | 69 |
spectrometry | 69 |
parameter | 69 |
sign | 69 |
solvent | 69 |
s1 | 69 |
reperfusion | 69 |
refractoriness | 69 |
recombination | 69 |
adv | 68 |
avidity | 68 |
demographics | 68 |
difficulties | 68 |
distress | 68 |
epidemic | 68 |
facilities | 68 |
homeostasis | 68 |
intron | 68 |
medrxiv | 68 |
mimicry | 68 |
mol | 68 |
resident | 68 |
run | 68 |
link | 68 |
fatigue | 67 |
leishmaniasis | 67 |
immunoglobulins | 67 |
h. | 67 |
agonist | 67 |
bacteremia | 67 |
astrocytes | 67 |
assembly | 67 |
minority | 67 |
loading | 67 |
ray | 67 |
modeling | 67 |
μl | 67 |
update | 67 |
tendency | 67 |
regulations | 67 |
nausea | 67 |
participation | 67 |
pancreas | 67 |
pair | 67 |
neonates | 67 |
flu | 66 |
acceptance | 66 |
allotypes | 66 |
antisera | 66 |
copy | 66 |
databases | 66 |
delay | 66 |
dengue | 66 |
eligibility | 66 |
flexibility | 66 |
functionality | 66 |
formulation | 66 |
provision | 66 |
yields | 66 |
ul | 66 |
sections | 66 |
shelf | 66 |
pi | 66 |
parallel | 66 |
major | 66 |
healing | 66 |
facility | 65 |
ages | 65 |
card | 65 |
cartilage | 65 |
coats | 65 |
cutoff | 65 |
experiment | 65 |
diet | 65 |
lot | 65 |
microbe | 65 |
oncology | 65 |
plate | 65 |
probe | 65 |
sct | 65 |
tubes | 65 |
manuscript | 65 |
genomes | 64 |
baby | 64 |
dysregulation | 64 |
elevation | 64 |
estimation | 64 |
food | 64 |
hbc141 | 64 |
ip | 64 |
minimum | 64 |
nk | 64 |
organism | 64 |
sarcoidosis | 64 |
signature | 64 |
morphology | 63 |
+100 | 63 |
aureus | 63 |
coefficient | 63 |
depression | 63 |
hypotension | 63 |
modality | 63 |
vessels | 63 |
mucosa | 63 |
plates | 63 |
questionnaires | 63 |
task | 63 |
tat | 63 |
titre | 63 |
trends | 63 |
insertion | 62 |
aspect | 62 |
boost | 62 |
copyright | 62 |
cytometric | 62 |
dosing | 62 |
figures | 62 |
frame | 62 |
lineages | 62 |
registration | 62 |
security | 62 |
today | 62 |
toxoplasmosis | 62 |
users | 62 |
iso | 62 |
beam | 61 |
immunoinformatics | 61 |
aims | 61 |
audit | 61 |
comorbidity | 61 |
funding | 61 |
heat | 61 |
kind | 61 |
lots | 61 |
microenvironment | 61 |
scheme | 61 |
statistics | 61 |
user | 61 |
waste | 61 |
ways | 61 |
gvl | 60 |
adjuvants | 60 |
art | 60 |
behavior | 60 |
cytomegalovirus | 60 |
detail | 60 |
variable | 60 |
indicator | 60 |
output | 60 |
regulator | 60 |
substances | 60 |
traceability | 60 |
drop | 59 |
determinant | 59 |
committee | 59 |
concordance | 59 |
defibrotide | 59 |
calculation | 59 |
axis | 59 |
allergy | 59 |
alignment | 59 |
force | 59 |
face | 59 |
pooling | 59 |
funder | 59 |
pulse | 59 |
instance | 59 |
scenario | 59 |
responder | 59 |
subpopulation | 59 |
thalassaemia | 59 |
policies | 59 |
perpetuity | 59 |
milk | 59 |
covid-19 | 58 |
accreditation | 58 |
aspergillosis | 58 |
bedside | 58 |
bottles | 58 |
bronchiolitis | 58 |
carrier | 58 |
completion | 58 |
matter | 58 |
fashion | 58 |
integrity | 58 |
nkg2d | 58 |
principle | 58 |
session | 58 |
shortage | 58 |
spite | 58 |
stock | 58 |
functioning | 57 |
assurance | 57 |
attempts | 57 |
cascade | 57 |
compounds | 57 |
diagnostics | 57 |
article | 57 |
immunodominance | 57 |
principles | 57 |
rash | 57 |
resuscitation | 57 |
specifications | 57 |
workers | 57 |
nf | 57 |
format | 56 |
meeting | 56 |
intake | 56 |
injections | 56 |
hpv | 56 |
mucositis | 56 |
ethnicity | 56 |
chimeras | 56 |
agitation | 56 |
actin | 56 |
mobilisation | 56 |
technologists | 56 |
obstruction | 56 |
relatives | 56 |
operating | 56 |
• | 56 |
subunits | 56 |
spread | 56 |
virions | 56 |
purposes | 56 |
pretreatment | 56 |
potency | 56 |
operation | 56 |
investigators | 55 |
autoantibody | 55 |
cd341 | 55 |
codon | 55 |
grant | 55 |
holder | 55 |
hosts | 55 |
necessity | 55 |
loads | 55 |
manipulation | 55 |
party | 55 |
plateletpheresis | 55 |
proteinuria | 55 |
thresholds | 55 |
trigger | 55 |
digestion | 54 |
abundance | 54 |
accessibility | 54 |
agonists | 54 |
biotin | 54 |
characteristic | 54 |
barriers | 54 |
father | 54 |
opportunities | 54 |
switch | 54 |
saturation | 54 |
hazards | 54 |
mo | 54 |
keratinocytes | 54 |
acquisition | 53 |
air | 53 |
allergens | 53 |
hla | 53 |
box | 53 |
capture | 53 |
clustering | 53 |
cut | 53 |
derivatives | 53 |
estimate | 53 |
experts | 53 |
fluids | 53 |
hemovigilance | 53 |
artery | 53 |
microbiome | 53 |
ordering | 53 |
suspensions | 53 |
wells | 53 |
travel | 53 |
translocation | 53 |
outbreaks | 53 |
teams | 53 |
toll | 53 |
sessions | 53 |
requests | 53 |
pre | 53 |
platforms | 53 |
picture | 53 |
classes | 52 |
infiltrate | 52 |
existence | 52 |
deletions | 52 |
considerations | 52 |
integration | 52 |
cd45ra | 52 |
bond | 52 |
bias | 52 |
atrophy | 52 |
alt | 52 |
inoculation | 52 |
downregulation | 52 |
liposomes | 52 |
reliability | 52 |
ml. | 52 |
urticaria | 52 |
transcript | 52 |
stat1 | 52 |
respondents | 52 |
targeting | 52 |
potassium | 52 |
portion | 52 |
vasculitis | 52 |
p24 | 52 |
outpatient | 52 |
cytometer | 51 |
ion | 51 |
infl | 51 |
eosinophils | 51 |
deterioration | 51 |
decisions | 51 |
datasets | 51 |
adsorptions | 51 |
cooperation | 51 |
citrate | 51 |
boys | 51 |
allocation | 51 |
aliquots | 51 |
maximum | 51 |
libraries | 51 |
neuroblastoma | 51 |
tumours | 51 |
shape | 51 |
workflow | 51 |
operator | 51 |
thawing | 51 |
supertype | 51 |
stabilization | 51 |
signatures | 51 |
snps | 51 |
screens | 51 |
researchers | 51 |
posttransplantation | 51 |
partners | 51 |
overlap | 51 |
overexpression | 51 |
costimulation | 50 |
explanation | 50 |
elution | 50 |
electron | 50 |
dermatitis | 50 |
degrees | 50 |
hormone | 50 |
color | 50 |
check | 50 |
b1 | 50 |
anaphylaxis | 50 |
adrs | 50 |
hematopoiesis | 50 |
lilrb2 | 50 |
instruments | 50 |
routine | 50 |
isotype | 50 |
transition | 50 |
transferrin | 50 |
tandem | 50 |
specifi | 50 |
speed | 50 |
rescue | 50 |
repair | 50 |
recommendation | 50 |
nephritis | 50 |
translation | 50 |
dialysis | 49 |
expiration | 49 |
evasion | 49 |
effectors | 49 |
disruption | 49 |
display | 49 |
bodies | 49 |
deviations | 49 |
costimulatory | 49 |
contacts | 49 |
compartments | 49 |
cholesterol | 49 |
girl | 49 |
immunodeficiencies | 49 |
nursing | 49 |
splenocytes | 49 |
organizations | 49 |
university | 49 |
turnover | 49 |
tables | 49 |
standardization | 49 |
visit | 49 |
relationships | 49 |
productivity | 49 |
pig | 49 |
parent | 49 |
rejuvenation | 49 |
colonies | 48 |
helix | 48 |
gain | 48 |
epidermis | 48 |
contrary | 48 |
bm | 48 |
chemical | 48 |
cat | 48 |
airways | 48 |
/l | 48 |
idea | 48 |
hepatocytes | 48 |
stores | 48 |
inability | 48 |
publications | 48 |
nucleocapsid | 48 |
society | 48 |
rris | 48 |
repertoires | 48 |
signalling | 48 |
48 | |
phosphatase | 48 |
perspective | 48 |
pbmc | 48 |
colleagues | 47 |
isoforms | 47 |
herpes | 47 |
ffp | 47 |
entity | 47 |
elispot | 47 |
cov | 47 |
= | 47 |
bed | 47 |
batch | 47 |
assessments | 47 |
absorption | 47 |
linkage | 47 |
# | 47 |
leukoreduction | 47 |
learning | 47 |
lysates | 47 |
root | 47 |
wall | 47 |
virulence | 47 |
tolerability | 47 |
titration | 47 |
sum | 47 |
satisfaction | 47 |
visualization | 47 |
regulators | 47 |
reactivations | 47 |
primer | 47 |
pbls | 47 |
p53 | 47 |
rearrangement | 47 |
counter | 46 |
fatality | 46 |
ed | 46 |
departments | 46 |
crystal | 46 |
counting | 46 |
authorities | 46 |
containers | 46 |
carbamazepine | 46 |
aspiration | 46 |
amphotericin | 46 |
alloantigen | 46 |
igm | 46 |
hybridization | 46 |
wbcs | 46 |
instability | 46 |
refinement | 46 |
kda | 46 |
urea | 46 |
spot | 46 |
regime | 46 |
regeneration | 46 |
scans | 46 |
reactivities | 46 |
qol | 46 |
odds | 46 |
n=7 | 46 |
law | 46 |
der | 45 |
interviews | 45 |
immunohistochemistry | 45 |
glycosylation | 45 |
fractures | 45 |
falciparum | 45 |
electrophoresis | 45 |
adjustment | 45 |
chemo | 45 |
cd | 45 |
capabilities | 45 |
bridges | 45 |
knockout | 45 |
abnormality | 45 |
ist | 45 |
top | 45 |
modalities | 45 |
rea | 45 |
n=9 | 45 |
trafficking | 45 |
tag | 45 |
sequelae | 45 |
reproducibility | 45 |
relative | 45 |
transporter | 45 |
providers | 45 |
phosphate | 45 |
particle | 45 |
nzb | 45 |
nurse | 45 |
predonation | 45 |
difficulty | 44 |
gold | 44 |
files | 44 |
evaluations | 44 |
doi | 44 |
dl. | 44 |
biomarker | 44 |
criterion | 44 |
crisis | 44 |
angle | 44 |
alteration | 44 |
incident | 44 |
iii | 44 |
hscts | 44 |
intention | 44 |
probabilities | 44 |
toxin | 44 |
topics | 44 |
tnfa | 44 |
rcts | 44 |
purpura | 44 |
therapeutics | 44 |
planning | 44 |
papain | 44 |
package | 44 |
limits | 44 |
kinases | 44 |
deposits | 43 |
hair | 43 |
goals | 43 |
freezing | 43 |
fluorescent | 43 |
eye | 43 |
endothelium | 43 |
depth | 43 |
cation | 43 |
dehydrogenase | 43 |
cytoskeleton | 43 |
cytochrome | 43 |
crystals | 43 |
cirrhosis | 43 |
charge | 43 |
head | 43 |
bead | 43 |
handling | 43 |
signifi | 43 |
height | 43 |
science | 43 |
μg | 43 |
institute | 43 |
vesicles | 43 |
verification | 43 |
threats | 43 |
third | 43 |
stroke | 43 |
subclass | 43 |
savings | 43 |
registries | 43 |
photopheresis | 43 |
phagocytes | 43 |
pet | 43 |
mouth | 43 |
mobilizers | 43 |
metabolites | 43 |
erythropoiesis | 42 |
erap1 | 42 |
erap2 | 42 |
genomics | 42 |
extension | 42 |
extracts | 42 |
harm | 42 |
encoding | 42 |
engineering | 42 |
allergen | 42 |
eluate | 42 |
egfr | 42 |
circumstances | 42 |
cd40l | 42 |
cd3 | 42 |
brother | 42 |
behalf | 42 |
/kg | 42 |
industry | 42 |
illumination | 42 |
spp | 42 |
inhabitants | 42 |
rs | 42 |
map | 42 |
µg | 42 |
yr | 42 |
vessel | 42 |
ultrasound | 42 |
sirolimus | 42 |
school | 42 |
scenarios | 42 |
twins | 42 |
reticulum | 42 |
prp | 42 |
professionals | 42 |
meetings | 42 |
preference | 42 |
obesity | 42 |
neurons | 42 |
microplate | 42 |
repeats | 42 |
hepatotoxicity | 41 |
labelling | 41 |
immunoassay | 41 |
ice | 41 |
aid | 41 |
extract | 41 |
chemotaxis | 41 |
audits | 41 |
-1 | 41 |
microparticles | 41 |
methodologies | 41 |
liquid | 41 |
mix | 41 |
separators | 41 |
working | 41 |
transgene | 41 |
suspicion | 41 |
splicing | 41 |
storm | 41 |
scanning | 41 |
rst | 41 |
overview | 41 |
nitrogen | 41 |
motivation | 41 |
eculizumab | 40 |
cv | 40 |
haemorrhage | 40 |
disparity | 40 |
disturbances | 40 |
file | 40 |
elasticity | 40 |
endoplasmic | 40 |
equation | 40 |
expressions | 40 |
clot | 40 |
clotting | 40 |
bottom | 40 |
city | 40 |
capability | 40 |
campaign | 40 |
c3 | 40 |
bypass | 40 |
bladder | 40 |
babies | 40 |
atoms | 40 |
arrest | 40 |
arginine | 40 |
activator | 40 |
haemolysis | 40 |
disaster | 40 |
hands | 40 |
representation | 40 |
hbc | 40 |
vvr | 40 |
virion | 40 |
tubing | 40 |
tail | 40 |
splenectomy | 40 |
spleens | 40 |
sorting | 40 |
shortages | 40 |
sarcoma | 40 |
s2 | 40 |
stimulus | 40 |
propensity | 40 |
incidents | 40 |
predisposition | 40 |
hd | 40 |
hemodialysis | 40 |
images | 40 |
homing | 40 |
negativity | 40 |
nucleotides | 40 |
paradigm | 40 |
pneumonitis | 40 |
leukemias | 39 |
grants | 39 |
leucodepletion | 39 |
intestine | 39 |
insufficiency | 39 |
infrastructure | 39 |
hbs | 39 |
abstracts | 39 |
dp | 39 |
clonotypes | 39 |
aspergillus | 39 |
amnion | 39 |
aivs | 39 |
abs | 39 |
ltx | 39 |
limitation | 39 |
immunohematology | 39 |
microarray | 39 |
puncture | 39 |
vision | 39 |
thyroid | 39 |
sizes | 39 |
sister | 39 |
similarities | 39 |
ranges | 39 |
uric | 39 |
promotion | 39 |
passage | 39 |
well | 39 |
nerve | 39 |
mmhg | 39 |
peer | 39 |
practitioners | 39 |
h-2 | 38 |
anastomosis | 38 |
behaviour | 38 |
calprotectin | 38 |
conjugate | 38 |
definitions | 38 |
deliveries | 38 |
dyspnea | 38 |
exercise | 38 |
formula | 38 |
fungal | 38 |
block | 38 |
hypoxia | 38 |
income | 38 |
oxide | 38 |
lead | 38 |
topic | 38 |
student | 38 |
schizophrenia | 38 |
theory | 38 |
nan | 38 |
mind | 38 |
methylation | 38 |
locations | 38 |
cd11b | 37 |
dexamethasone | 37 |
desensitization | 37 |
dependence | 37 |
counterparts | 37 |
compound | 37 |
cellularity | 37 |
avoidance | 37 |
carbohydrate | 37 |
calcineurin | 37 |
boy | 37 |
backbone | 37 |
24h | 37 |
division | 37 |
dimer | 37 |
perception | 37 |
hybridomas | 37 |
oxidation | 37 |
ifns | 37 |
specialists | 37 |
plots | 37 |
plasmas | 37 |
perfusion | 37 |
t. | 37 |
plot | 37 |
neoplasia | 37 |
neonate | 37 |
mycobacteria | 37 |
mutant | 37 |
lymphokine | 37 |
interview | 37 |
determinations | 36 |
hev | 36 |
headache | 36 |
girls | 36 |
germ | 36 |
evs | 36 |
document | 36 |
dissemination | 36 |
dimers | 36 |
cavity | 36 |
demonstration | 36 |
d1 | 36 |
contents | 36 |
container | 36 |
columns | 36 |
cd62l | 36 |
inheritance | 36 |
anticoagulant | 36 |
alemtuzumab | 36 |
infarction | 36 |
graftversus | 36 |
layers | 36 |
posttransfusion | 36 |
ligation | 36 |
vomiting | 36 |
tracking | 36 |
testosterone | 36 |
subclasses | 36 |
rna | 36 |
reading | 36 |
quantitation | 36 |
scope | 36 |
placenta | 36 |
past | 36 |
nutrition | 36 |
notion | 36 |
needle | 36 |
n=1 | 36 |
microglia | 36 |
pathophysiology | 36 |
microbes | 36 |
lives | 35 |
glass | 35 |
government | 35 |
indices | 35 |
metrics | 35 |
lysate | 35 |
market | 35 |
meningitis | 35 |
erythropoietin | 35 |
finger | 35 |
accessory | 35 |
equilibrium | 35 |
ease | 35 |
degranulation | 35 |
creation | 35 |
chamber | 35 |
band | 35 |
autophagy | 35 |
alveolar | 35 |
alert | 35 |
name | 35 |
microscope | 35 |
achievement | 35 |
opinion | 35 |
serostatus | 35 |
vehicle | 35 |
vod | 35 |
usefulness | 35 |
transferase | 35 |
threat | 35 |
surfaces | 35 |
supplement | 35 |
situ | 35 |
simulations | 35 |
phone | 35 |
seroprevalence | 35 |
routes | 35 |
residents | 35 |
refractory | 35 |
property | 35 |
pressures | 35 |
presentations | 35 |
prednisone | 35 |
possibilities | 35 |
pipeline | 35 |
exosomes | 34 |
followup | 34 |
glands | 34 |
hemagglutinin | 34 |
hepatocyte | 34 |
interferons | 34 |
immunisation | 34 |
immunosuppressants | 34 |
infancy | 34 |
infiltrates | 34 |
disability | 34 |
lavage | 34 |
dissociation | 34 |
century | 34 |
dilutions | 34 |
delays | 34 |
crp | 34 |
complaints | 34 |
leucocytes | 34 |
cd62p | 34 |
caspase | 34 |
cart | 34 |
capacities | 34 |
bet | 34 |
beds | 34 |
barcode | 34 |
attitude | 34 |
answers | 34 |
letter | 34 |
hybrid | 34 |
matches | 34 |
reverse | 34 |
™ | 34 |
message | 34 |
® | 34 |
urate | 34 |
tomography | 34 |
split | 34 |
splice | 34 |
spin | 34 |
sedimentation | 34 |
schedules | 34 |
runs | 34 |
rules | 34 |
rule | 34 |
rubella | 34 |
ß | 34 |
remissions | 34 |
pharmacokinetics | 34 |
rearrangements | 34 |
neck | 34 |
neoplasm | 34 |
normalization | 34 |
percentile | 34 |
language | 34 |
phlebotomy | 34 |
polysaccharide | 34 |
prerequisite | 34 |
priority | 34 |
polarization | 34 |
rationale | 34 |
diameter | 33 |
d2 | 33 |
derivates | 33 |
description | 33 |
developments | 33 |
excess | 33 |
encephalopathy | 33 |
correlates | 33 |
expert | 33 |
favor | 33 |
foxp3 | 33 |
gp | 33 |
cryo | 33 |
coagulopathy | 33 |
connection | 33 |
conjunction | 33 |
clinics | 33 |
cidofovir | 33 |
chimera | 33 |
breadth | 33 |
blotting | 33 |
bacterium | 33 |
aspirin | 33 |
angiotensin | 33 |
act | 33 |
granule | 33 |
calculations | 33 |
hrs | 33 |
hallmark | 33 |
provider | 33 |
ions | 33 |
utero | 33 |
temperatures | 33 |
synapse | 33 |
starting | 33 |
ssc | 33 |
splenomegaly | 33 |
smoking | 33 |
scleroderma | 33 |
row | 33 |
receiver | 33 |
publication | 33 |
workload | 33 |
proteomics | 33 |
neoplasms | 33 |
profiling | 33 |
lifestyle | 33 |
lipids | 33 |
myelin | 33 |
myelogenous | 33 |
path | 33 |
penicillin | 33 |
polypeptide | 33 |
predominance | 33 |
pretransfusion | 33 |
hemostasis | 32 |
eosinophilia | 32 |
formulations | 32 |
gap | 32 |
guide | 32 |
knee | 32 |
hit | 32 |